References
- Vardakas KZ, Matthaiou DK, Falagas ME, et al. Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. Infect Dis (Lond). 2015;47:751–753.
- Nation RL, Velkov T, Li J. Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis. 2014;59:88–94.
- Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55:3002–3004.
- Centers for Disease Control and Prevention. Modified Hodge Test for Carbapenamase Detection in Enterobacteriaceace; [cited 2017 Mar 3]. Available at: https://www.cdc.gov/hai/pdfs/labsettings/hodgetest_carbapenemase_enterobacteriaceae.pdf.
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter. Suppl 2012;2:1–138.
- Garonzik SM, Li J, Thamlikitkul V, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically Ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284–3294.
- Souli M, Karaiskos I, Masgala A, et al. Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella Pneumoniae. Eur J Clin Microbiol Infect Dis. 2017. [Epub ahead of print].
- Poirel L, Keiffer N, Nordmann P. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2016;71:156–161.
- Avycaz (ceftazidime/avibactam) [package insert]. Cincinatti, OH: Forest Pharmaceuticals; 2016.
- Shields RK, Potoski BA, Haidar G, et al. Clinical outcomes, drug toxicity, and emergence of ceftazidime–avibactam resistance among patients treated for carbapenem-resistant enterobacteriaceae infections. Clin Infect Dis. 2016;63:1615–1618.
- Humphries RM, Yang S, Hemarajata P, et al. First report of ceftazidime–avibactam resistance in a KPC-3 expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother. 2015;59:6605–6607.